US|EN
Select your region & language
Our content and services may vary by location.
US|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 114207

Market Access Manager

  • Pharma & Biotech
  • Asap
  • Launch Pricing Strategies, US & EU Market, Biotech
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-614

julius.strack@k-recruiting.com

Overview

Availability
Asap, 5 days/week, on-site & remote
Qualification
Ph. D. Biology
Language Skills
German (native), English (business fluent)
Relevant Expertise
Pricing & Market Access, Launch Pricing Strategies, Reimbursement Strategies, US & EU Market, Cross-Indication Strategies, Project Management, Biotech, Pharma, Rare & Ultra-Rare Diseases

Key-Facts

  • Highly accomplished Pricing & Market Access expert with significant experience in launch pricing strategy, P&R plans, cross-indication strategy, value proposition development, global commercial opportunity and country-level implementation strategies

  • Deep knowledge of US (Medicare & Medicaid) and EU payer market systems, and conducting primary research with payers and other key stakeholders in these markets

Extract from previous activities

07/2022 – date

Pharmaceutical Company, Germany

Market Access Manager

  • Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

  • Strategic market access options development, including a list of contracting options, for cystic fibrosis to drive commercial planning activities

11/2021 – 06/2022

Pharmaceutical Company, Germany

Pricing & Market Access Manager

  • C Global P&MA strategy for a novel gene therapy in hemophilia B (US, EU5, Brazil & Japan)

  • Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

01/2021 - 11/2021

Pharmaceutical Company, Germany

Market Access Manager

  • Strategic market access options development, including a menu of contracting options, for cystic fibrosis to drive commercial planning activities

  • Cross-indication P&MA assessment for an orphan drug for a rare nephrology disorder (US & EU)

12/2019 - 12/2020

Pricing & Market Access Consultant

Pricing & Market Access Consultant

  • Managed over 50 EU-based and global projects focused on pricing & market access strategy for tier 1 pharmaceutical companies

  • Developed expert knowledge of US and EU markets and experienced working with payers across US, CA, EU, LATAM and APAC